Milestone! Australia’s TGA Confirms NMN as a Compliant Supplement Ingredient
The global anti-ageing and longevity industry has reached a significant regulatory milestone as Australia’s Therapeutic Goods Administration (TGA) formally recognises β-Nicotinamide Mononucleotide (NMN) as a compliant ingredient for use in listed complementary medicines. This decision provides long-awaited regulatory clarity for NMN-based supplements in the Australian market and marks a critical step toward greater standardisation, safety, and consumer confidence.
Under the updated regulatory framework, NMN may be included in TGA-listed (AUST L) products, provided that manufacturers comply with ingredient quality, safety, labelling, and manufacturing standards. This move effectively removes NMN from its previous regulatory grey area and positions Australia as one of the more progressive markets for compliant longevity and healthy ageing supplements.
Global Anti-Ageing Market Snapshot
As global populations age at an unprecedented pace, declining cellular energy and resilience have emerged as central challenges of modern health. One of the key biological drivers of this trend is the natural age-related reduction of NAD⁺ levels, a molecule essential for cellular metabolism, DNA repair, and energy production. This gradual decline is increasingly associated with fatigue, slower metabolic function, and reduced cellular repair capacity—factors that collectively contribute to the broader ageing crisis faced by individuals and healthcare systems alike. NMN (β-Nicotinamide Mononucleotide), a direct precursor to NAD⁺, has therefore attracted growing attention as a foundational ingredient in next-generation longevity and healthy ageing formulations, positioned to support cellular vitality in an ageing world.
Internationally, NMN continues to gain prominence as a core longevity nutrient due to its role in supporting cellular energy and healthy ageing pathways. A notable example on the market is Genex Formulas NMN, a high-strength NMN supplement widely recognised for its purity and straightforward formulation designed to support healthy ageing and metabolic function.
A Reliable NMN Raw Material Partner
In alignment with evolving global regulations and market demand, Xi’an HiHealth Biotechnology offers premium, high-purity NMN powder tailored for supplement manufacturers and brands seeking compliant raw material sources for next-generation health products.
Key advantages include:
High purity and quality consistency for reliable formulation performance
Compatibility across delivery formats, including capsules, tablets, and bulk powders
Scalable supply capacity ideal for commercial production
Well-positioned for regulated markets such as TGA-listed supplements
As NMN continues to transition from an emerging ingredient to a regulated, mainstream component of longevity, reliable raw material sourcing becomes increasingly critical. Our NMN is positioned to support brands seeking to develop compliant, high-quality anti-ageing supplements in Australia and globally.
Toward a Healthier, Longer Life
Looking ahead, humanity’s pursuit of healthy aging is entering a more science-driven and regulated era. Rather than seeking to reverse aging itself, the focus is increasingly shifting toward extending healthspan, preserving cellular function, and supporting quality of life as populations live longer. Advances in nutritional science, molecular biology, and regulatory frameworks are enabling longevity solutions to move from experimental concepts to responsibly developed products. Ingredients such as NMN, supported by growing research and clearer compliance pathways, are becoming part of a broader strategy to help individuals age with resilience, vitality, and dignity. As science, regulation, and consumer awareness continue to align, the future of healthy aging holds the promise of not only longer lives, but better lives.
ze@hihealthbio.com